Breakthrough Chemistry Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-0.22	-0.22	-0.19	-0.15
Depreciation & Amortization	0.04	0.04	0.03	-
Asset Writedown & Restructuring Costs	0.04	0.04	0.02	-
Other Operating Activities	-	0.01	0.03	0.08
Change in Accounts Receivable	0.01	-0	-	-
Change in Inventory	0.01	0.01	-0	0.01
Change in Accounts Payable	0.02	0.02	0.03	-0.01
Change in Other Net Operating Assets	0	0	-0	-0
Operating Cash Flow	-0.1	-0.1	-0.09	-0.08
Short-Term Debt Issued	-	-	0.03	0.03
Total Debt Issued	-	-	0.03	0.03
Net Debt Issued (Repaid)	-	-	0.03	0.03
Other Financing Activities	0.1	0.1	0.05	0.07
Financing Cash Flow	0.1	0.1	0.08	0.09
Net Cash Flow	0	0	-0.01	0.02
Levered Free Cash Flow	-	-0.03	-0.16	-
Unlevered Free Cash Flow	-	-0	-0.12	-
Change in Working Capital	0.04	0.03	0.03	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.